Emergent Biosolutions lays off 300 people [Yahoo! Finance]
Emergent Biosolutions, Inc. (EBS)
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Yahoo! Finance
The layoffs and restructuring were announced Wednesday. Lansing's BioPort — the only company in the nation that produced an anthrax vaccine — is a subsidiary of Emergent BioSolutions. The company makes Narcan nasal spray, a rapid opioid overdose reversal drug. This embedded content is not available in your region. In a news release the company says the realignment “are expected to result in annualized savings of approximately $80 million when fully implemented.” “Today's actions are about the future of Emergent,” said CEO Joe Papa. “We have put in place a multi-year plan to position Emergent for sustainable and long-term success, and that starts by stabilizing our operations, strengthening our balance sheet and managing our debt.” Wall Street reacted positively to the news. The stock was trading at $1.93 Wednesday. Thursday it closed at $3.30. It's peak was $133.42 a share in August of 2020. In February 2024, it was trading at just $1.50 a share. For the latest news, weat
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent Biosolutions, Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Walgreens launches its own opioid reversal therapy for OTC use [Seeking Alpha]Seeking Alpha
- Walgreens launches own brand of opioid overdose reversal drug [Reuters]Reuters
- Walgreens launches own brand of opioid overdose reversal drug [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024GlobeNewswire
EBS
Earnings
- 3/6/24 - Miss
EBS
Sec Filings
- 5/2/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 5/1/24 - Form 8-K
- EBS's page on the SEC website